站在产业视角，这笔交易折射出全球抗癌药物研发的新趋势。据EvaluatePharma预测，到2030年RAS抑制剂市场规模将突破200亿美元，其中KRAS靶点占比超七成。中国创新药企通过差异化布局，正在改写全球竞争格局：在KRAS-G12C领域，安进、Mirati等国际药企已建立先发优势，而针对KRAS非经典突变及泛RAS抑制的赛道仍存巨大空白。JYP0015的临床推进，标志着我国在新一代肿瘤靶向 ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

智通财经APP获悉，2月17日，中国国家药监局药品审评中心(CDE)官网公示，辉瑞(PFE.US)(Pfizer)1类新药PF-07934040片获得临床试验默示许可，拟开发治疗携带KRAS突变的晚期实体瘤。根据辉瑞公司公开资料，这是一款在研泛KRA ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

The 2025 Great American Outdoors Show continued to draw crowds to the Pennsylvania Farm Show Complex in Harrisburg on Thursday. The annual event, sponsored by the National Rifle Association ...

We've identified the following companies as similar to Hera S.p.A. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow ...

Deep learning–powered analysis of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does ...

Preclinical analysis and clinical validation to identify biomarkers for trifluridine/tipiracil (FTD/TPI) efficacy with or without bevacizumab in patients with metastatic colorectal cancer. This is an ...

Insilico Medicine’s Robotics Lab in Suzhou, China. Researchers from the artificial intelligence (AI)-based drug developer and the University of Toronto showed in a newly published study how AI ...

ISM061-018-2 同时对另外五种常见突变型 KRAS 以及野生型 HRAS、NRAS 展示出了剂量依赖的抑制活性，这一结果展示了其作为具有全新结构的泛 RAS 抑制剂的 ...

Photos courtesy of LWRCI.com. LWRC International has built a reputation for its semi-automatic guns, and new for 2025, from the Maryland-based gunmaker is the latest advancement in the brand’s ...

Every generation brings about changes to the way we work—in particular with their expectations for the workplace experience and benefits. With previous generations, we saw companies pivot from ...